| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytidine deaminase activity | 2.14e-05 | 13 | 86 | 3 | GO:0004126 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.54e-06 | 6 | 89 | 3 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.54e-06 | 6 | 89 | 3 | GO:0099046 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 9.12e-06 | 10 | 89 | 3 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 1.66e-05 | 12 | 89 | 3 | GO:0016554 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 2.73e-05 | 14 | 89 | 3 | GO:0006216 | |
| GeneOntologyBiologicalProcess | DNA deamination | 2.73e-05 | 14 | 89 | 3 | GO:0045006 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 2.73e-05 | 14 | 89 | 3 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 2.73e-05 | 14 | 89 | 3 | GO:0009972 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 4.18e-05 | 16 | 89 | 3 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 4.18e-05 | 16 | 89 | 3 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 4.18e-05 | 16 | 89 | 3 | GO:0046133 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 5.45e-05 | 48 | 89 | 4 | GO:0009119 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 6.05e-05 | 18 | 89 | 3 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 7.16e-05 | 19 | 89 | 3 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 7.16e-05 | 19 | 89 | 3 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 8.39e-05 | 20 | 89 | 3 | GO:0039692 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 1.88e-04 | 26 | 89 | 3 | GO:0042454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 2.11e-04 | 27 | 89 | 3 | GO:0006213 | |
| GeneOntologyBiologicalProcess | nucleoside metabolic process | 2.14e-04 | 68 | 89 | 4 | GO:0009116 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 2.90e-04 | 30 | 89 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | DNA modification | 3.20e-04 | 31 | 89 | 3 | GO:0006304 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 3.52e-04 | 32 | 89 | 3 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 3.52e-04 | 32 | 89 | 3 | GO:0009164 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 5.43e-04 | 37 | 89 | 3 | GO:0034656 | |
| Domain | APOBEC_N | 1.88e-05 | 12 | 84 | 3 | PF08210 | |
| Domain | APOBEC_N | 1.88e-05 | 12 | 84 | 3 | IPR013158 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 3.08e-05 | 14 | 84 | 3 | IPR016192 | |
| Domain | Cytidine_deaminase-like | 5.70e-05 | 17 | 84 | 3 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 5.70e-05 | 17 | 84 | 3 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 5.70e-05 | 17 | 84 | 3 | IPR002125 | |
| Domain | MBT | 7.05e-04 | 9 | 84 | 2 | SM00561 | |
| Domain | MBT | 7.05e-04 | 9 | 84 | 2 | PS51079 | |
| Domain | MBT | 8.79e-04 | 10 | 84 | 2 | PF02820 | |
| Domain | Mbt | 8.79e-04 | 10 | 84 | 2 | IPR004092 | |
| Domain | CarboxyPept_regulatory_dom | 1.51e-03 | 13 | 84 | 2 | IPR014766 | |
| Domain | - | 1.51e-03 | 13 | 84 | 2 | 2.60.40.1120 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 2.02e-03 | 15 | 84 | 2 | PS51747 | |
| Domain | GPCR_2_secretin-like | 2.50e-03 | 60 | 84 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 2.50e-03 | 60 | 84 | 3 | IPR017981 | |
| Domain | CarboxyPept-like_regulatory | 2.60e-03 | 17 | 84 | 2 | IPR008969 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.62e-03 | 61 | 84 | 3 | PS50261 | |
| Domain | Zn_pept | 2.92e-03 | 18 | 84 | 2 | SM00631 | |
| Domain | CARBOXYPEPT_ZN_1 | 3.60e-03 | 20 | 84 | 2 | PS00132 | |
| Domain | FA58C | 3.97e-03 | 21 | 84 | 2 | SM00231 | |
| Domain | FA58C_3 | 3.97e-03 | 21 | 84 | 2 | PS50022 | |
| Domain | FA58C_1 | 3.97e-03 | 21 | 84 | 2 | PS01285 | |
| Domain | FA58C_2 | 3.97e-03 | 21 | 84 | 2 | PS01286 | |
| Domain | Peptidase_M14 | 4.76e-03 | 23 | 84 | 2 | PF00246 | |
| Domain | GABAA/Glycine_rcpt | 4.76e-03 | 23 | 84 | 2 | IPR006028 | |
| Domain | Peptidase_M14 | 4.76e-03 | 23 | 84 | 2 | IPR000834 | |
| Pubmed | The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. | 1.68e-08 | 3 | 90 | 3 | 23001005 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 20943965 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 19088851 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 19535450 | ||
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 18702815 | ||
| Pubmed | Species-specific restriction of apobec3-mediated hypermutation. | 6.69e-08 | 4 | 90 | 3 | 18032489 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 18577210 | ||
| Pubmed | AID and APOBECs span the gap between innate and adaptive immunity. | 1.67e-07 | 5 | 90 | 3 | 25352838 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 18304004 | ||
| Pubmed | Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif. | 1.67e-07 | 5 | 90 | 3 | 20012521 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 25461536 | ||
| Pubmed | Structure-guided analysis of the human APOBEC3-HIV restrictome. | 3.33e-07 | 6 | 90 | 3 | 24657093 | |
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 22205746 | ||
| Pubmed | Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. | 3.33e-07 | 6 | 90 | 3 | 22912627 | |
| Pubmed | APOBEC3 proteins mediate the clearance of foreign DNA from human cells. | 5.82e-07 | 7 | 90 | 3 | 20062055 | |
| Pubmed | APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. | 5.82e-07 | 7 | 90 | 3 | 16527742 | |
| Pubmed | An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. | 5.82e-07 | 7 | 90 | 3 | 11863358 | |
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 21835787 | ||
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 24227842 | ||
| Pubmed | The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation. | 1.39e-06 | 9 | 90 | 3 | 25408426 | |
| Pubmed | 1.98e-06 | 10 | 90 | 3 | 23043103 | ||
| Pubmed | Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS. | 1.98e-06 | 10 | 90 | 3 | 20174454 | |
| Pubmed | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. | 2.72e-06 | 11 | 90 | 3 | 22915799 | |
| Pubmed | 2.72e-06 | 11 | 90 | 3 | 12683974 | ||
| Pubmed | 4.91e-06 | 257 | 90 | 7 | 16335952 | ||
| Pubmed | 6.43e-06 | 100 | 90 | 5 | 10048485 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 37454738 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11553610 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12925892 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 36632222 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 6.62e-06 | 2 | 90 | 2 | 12895410 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 27581978 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 8922996 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 8.13e-06 | 49 | 90 | 4 | 8951372 | |
| Pubmed | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. | 1.11e-05 | 17 | 90 | 3 | 24189052 | |
| Pubmed | Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. | 1.33e-05 | 18 | 90 | 3 | 20096141 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.98e-05 | 3 | 90 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.98e-05 | 3 | 90 | 2 | 27602762 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18806783 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.98e-05 | 3 | 90 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.98e-05 | 3 | 90 | 2 | 24577894 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18846074 | ||
| Pubmed | APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G. | 1.98e-05 | 3 | 90 | 2 | 27289067 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.98e-05 | 3 | 90 | 2 | 16648136 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11776052 | ||
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.98e-05 | 3 | 90 | 2 | 23533681 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 1541833 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 27356895 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.98e-05 | 3 | 90 | 2 | 25589647 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.98e-05 | 3 | 90 | 2 | 31518043 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 15878864 | ||
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.98e-05 | 3 | 90 | 2 | 24840555 | |
| Pubmed | Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes. | 1.98e-05 | 3 | 90 | 2 | 24248339 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 9765497 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 24453360 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23449789 | ||
| Pubmed | APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model. | 1.98e-05 | 3 | 90 | 2 | 25330146 | |
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.98e-05 | 3 | 90 | 2 | 18434399 | |
| Pubmed | HPA-genotyping and antiplatelet antibodies in female blood donors. | 1.98e-05 | 3 | 90 | 2 | 14671618 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.98e-05 | 3 | 90 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.98e-05 | 3 | 90 | 2 | 18772436 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 15389531 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22807680 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.98e-05 | 3 | 90 | 2 | 18786991 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 286744 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 24725948 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 20702647 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 20980520 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 284359 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 20617165 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 31801862 | ||
| Pubmed | The structure of the talin/integrin complex at a lipid bilayer: an NMR and MD simulation study. | 1.98e-05 | 3 | 90 | 2 | 20947017 | |
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.98e-05 | 3 | 90 | 2 | 39208378 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 31943071 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 25724652 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.98e-05 | 3 | 90 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.98e-05 | 3 | 90 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.98e-05 | 3 | 90 | 2 | 25505062 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 31595054 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.98e-05 | 3 | 90 | 2 | 17967065 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.98e-05 | 3 | 90 | 2 | 29593034 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 31830125 | ||
| Pubmed | Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth. | 1.98e-05 | 3 | 90 | 2 | 30518533 | |
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.98e-05 | 3 | 90 | 2 | 21998583 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.98e-05 | 3 | 90 | 2 | 38115583 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 28101374 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 39060657 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.98e-05 | 3 | 90 | 2 | 35458563 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22275865 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 293683 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 19150103 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26537685 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.98e-05 | 3 | 90 | 2 | 12466850 | |
| Pubmed | GPR180 TDRD3 SETX IGF2R MAN2A1 DSP CARS1 CPD APOBEC3C ARIH1 ITGB1 ALKBH5 DYNC1H1 | 2.90e-05 | 1297 | 90 | 13 | 33545068 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | GPR180 IGF2R POLR1A USP9X FAM20B NUP133 CPD SARAF PJA1 PTGES3 DYNC1H1 | 3.22e-05 | 942 | 90 | 11 | 31073040 |
| Cytoband | 22q11.2 | 4.13e-06 | 120 | 90 | 5 | 22q11.2 | |
| Cytoband | 13q32.1 | 4.48e-04 | 16 | 90 | 2 | 13q32.1 | |
| Cytoband | 22q13.1 | 6.41e-04 | 85 | 90 | 3 | 22q13.1 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 1.24e-05 | 12 | 71 | 3 | 406 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 2.60e-05 | 89 | 71 | 5 | 353 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 5.38e-04 | 9 | 71 | 2 | 1263 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.49e-03 | 19 | 71 | 2 | 563 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TDRD3 SMARCA5 ADAMTSL1 SCML2 DSP USP9X TLL1 YLPM1 NUP133 CPD PTGFR L3MBTL3 ADGRA3 | 2.35e-05 | 836 | 84 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-06 | 172 | 89 | 6 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-06 | 185 | 89 | 6 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.14e-06 | 188 | 89 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-06 | 190 | 89 | 6 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-06 | 190 | 89 | 6 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 2.28e-06 | 190 | 89 | 6 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-06 | 190 | 89 | 6 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 2.28e-06 | 190 | 89 | 6 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.49e-06 | 193 | 89 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.49e-06 | 193 | 89 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 197 | 89 | 6 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-06 | 200 | 89 | 6 | 9b614b8b949aa7d3ddbe613db6e08adaf04535a7 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-06 | 133 | 89 | 5 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-05 | 145 | 89 | 5 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 156 | 89 | 5 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | Parenchymal-10x3prime_v2-Hematologic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-05 | 25 | 89 | 3 | 7b267cdcb6afcf603d566c4d5268eb44eacf47b6 | |
| ToppCell | Parenchymal-10x3prime_v2-Hematologic-Erythrocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-05 | 25 | 89 | 3 | 096ca30d9277cfd9cb2501c40b085cc358cb628b | |
| ToppCell | Parenchymal-10x3prime_v2-Hematologic-Erythrocyte-Erythrocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-05 | 25 | 89 | 3 | 3d7b43ecf6ae64996d91765c50f614742e18bd25 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-05 | 175 | 89 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-05 | 175 | 89 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | ASK428-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.83e-05 | 177 | 89 | 5 | 66074a288501c136b4e83b883db5f0d8269ee326 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-05 | 179 | 89 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-05 | 180 | 89 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 182 | 89 | 5 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 3.23e-05 | 182 | 89 | 5 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 3.59e-05 | 186 | 89 | 5 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.59e-05 | 186 | 89 | 5 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-05 | 186 | 89 | 5 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.77e-05 | 188 | 89 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 188 | 89 | 5 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.87e-05 | 189 | 89 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 3.87e-05 | 189 | 89 | 5 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.07e-05 | 191 | 89 | 5 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-05 | 191 | 89 | 5 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.07e-05 | 191 | 89 | 5 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 4.07e-05 | 191 | 89 | 5 | 7a28905ad504979497836e87df81d529e675ce78 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-05 | 191 | 89 | 5 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-05 | 191 | 89 | 5 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.07e-05 | 191 | 89 | 5 | 2b05be1888cccd03a32341bcb1de4a899d4179fd | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.17e-05 | 192 | 89 | 5 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 193 | 89 | 5 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 193 | 89 | 5 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-05 | 193 | 89 | 5 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.27e-05 | 193 | 89 | 5 | 6e9912f5444c591e698b9a7ffa3e9fc3d8ee57b0 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 4.38e-05 | 194 | 89 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 4.38e-05 | 194 | 89 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.38e-05 | 194 | 89 | 5 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.38e-05 | 194 | 89 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-05 | 195 | 89 | 5 | caa3669739974b63470f7e557df96e8d3844dd84 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.49e-05 | 195 | 89 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.49e-05 | 195 | 89 | 5 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-05 | 195 | 89 | 5 | bc5728e9df0b15adec50a7c840ce9f2775135087 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.49e-05 | 195 | 89 | 5 | ecaaa3d071e763c40d05d088fbf9e8ca06f78f47 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.60e-05 | 196 | 89 | 5 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 196 | 89 | 5 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.71e-05 | 197 | 89 | 5 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.83e-05 | 198 | 89 | 5 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 5.06e-05 | 200 | 89 | 5 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-05 | 200 | 89 | 5 | 0655328373d1b58828e141ddb0dcbb2cce10dc50 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 130 | 89 | 4 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 139 | 89 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 148 | 89 | 4 | 1186ee0d15244fee74c1d09df3967c1b69f8ddce | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 148 | 89 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.27e-04 | 149 | 89 | 4 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-04 | 150 | 89 | 4 | 98fdc6bdfde84d680e11d8727502b79afbf64303 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-04 | 150 | 89 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 151 | 89 | 4 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_CTL|Int-URO / Disease, Lineage and Cell Type | 2.51e-04 | 153 | 89 | 4 | fdc7dfa8f4db90bfdc7180bf178cf6d2dd064d97 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 2.57e-04 | 154 | 89 | 4 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.63e-04 | 155 | 89 | 4 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 155 | 89 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 157 | 89 | 4 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 157 | 89 | 4 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 159 | 89 | 4 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.90e-04 | 159 | 89 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-04 | 160 | 89 | 4 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.97e-04 | 160 | 89 | 4 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-04 | 161 | 89 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 162 | 89 | 4 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 165 | 89 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 165 | 89 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 3.50e-04 | 167 | 89 | 4 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-04 | 167 | 89 | 4 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 169 | 89 | 4 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 169 | 89 | 4 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 169 | 89 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.74e-04 | 170 | 89 | 4 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 3.74e-04 | 170 | 89 | 4 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-04 | 170 | 89 | 4 | 059f7ae615342ea19f43b0a405cd7272251a78a9 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 172 | 89 | 4 | b440184f2d98d2f2d59566795f44fb79c0647ca4 | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 3.91e-04 | 172 | 89 | 4 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-04 | 175 | 89 | 4 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 4.17e-04 | 175 | 89 | 4 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.17e-04 | 175 | 89 | 4 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 175 | 89 | 4 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 175 | 89 | 4 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 175 | 89 | 4 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 176 | 89 | 4 | a23d484aff5ad094333b2feae9106ca219514711 | |
| Disease | X-11315 measurement | 4.44e-04 | 11 | 85 | 2 | EFO_0021223 | |
| Disease | R-warfarin measurement | 1.03e-03 | 265 | 85 | 5 | EFO_0803324 | |
| Disease | partial epilepsy | 1.08e-03 | 17 | 85 | 2 | EFO_0004263 | |
| Disease | diet measurement, body mass index | 1.51e-03 | 20 | 85 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | diffuse plaque measurement | 1.54e-03 | 758 | 85 | 8 | EFO_0010699 | |
| Disease | left atrial function | 1.66e-03 | 21 | 85 | 2 | EFO_0004294 | |
| Disease | Parkinson Disease | 1.92e-03 | 85 | 85 | 3 | C0030567 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QREDEDDYEAAYWAS | 271 | Q96P26 | |
| RYAWQDDFLEDFLCF | 246 | P0CF97 | |
| CYLVYEFDKFWFEEE | 246 | Q8IZ81 | |
| RVKIMDYEDFAYCWE | 156 | Q96AK3 | |
| DYEDFAYCWENFVCN | 161 | Q96AK3 | |
| DDYYDGAWCAEDDAR | 426 | Q8IUX7 | |
| LFSVCLWFSEDYKEY | 211 | Q4VNC1 | |
| WADDDYSRCQYANDV | 406 | Q8IWK6 | |
| NYWRKSYESSEDCSE | 366 | Q6P6C2 | |
| EIMDYEDFKYCWENF | 146 | Q9NRW3 | |
| EDFKYCWENFVYNDN | 151 | Q9NRW3 | |
| SYDDYMWDKSCDYLF | 141 | Q96NL8 | |
| DFYNCWKETEAEAQE | 691 | A2RUS2 | |
| AAFYARYRVDEDWCL | 381 | Q9H3Z7 | |
| YVYKNGTETEDCFWY | 191 | P25092 | |
| CKEKDVDDCWFYFTY | 691 | P05556 | |
| YSDCYDFWVNADALD | 301 | Q96JM7 | |
| WYNCNRYNEDDAKAA | 386 | Q9Y4X5 | |
| ENFSWYLEDNIKTYC | 226 | P00450 | |
| ATLAYRWDCSDYEDT | 446 | Q6IWH7 | |
| YLWAASLAEKYCDFD | 856 | Q8WUM0 | |
| DLANPEYSNFCYWRE | 826 | Q9BQK8 | |
| SIDYEENKLYWCDAR | 2046 | Q9NZR2 | |
| YDRVQADNNDYWTEC | 1261 | Q71F56 | |
| WDDYKAFYEGERCSF | 616 | Q8IV33 | |
| DFRYCEYTEWDLQFK | 426 | Q16706 | |
| QSEDEADYYCAIWYS | 106 | A0A0G2JS06 | |
| SEDEADYYCKAWDNS | 101 | A0A075B6I6 | |
| SECQDSLTNWYYEKD | 41 | P53671 | |
| DELYDWEYEGFTKCS | 606 | Q8N6G6 | |
| FEYAWCLVRSKYNDD | 36 | Q9Y3D6 | |
| CFYNTEDIKDWEDRF | 186 | P43088 | |
| EDEADYYCAAWDDSL | 101 | P01700 | |
| YCIEWAARISEEYFS | 736 | O60658 | |
| EDEADYYCAAWDDSL | 101 | P01699 | |
| YVAETEEGIYWRYCD | 101 | Q8NCW0 | |
| IFSQTWYDERLCYND | 121 | P78334 | |
| WYDERLCYNDTFESL | 126 | P78334 | |
| ADADENFYTCAWTYD | 141 | O75530 | |
| YWRDNYTCPTEEEYK | 131 | O95749 | |
| SRSKAEAEAWYQCRY | 301 | Q9NSB4 | |
| FKWLCYSNEAEEFIF | 81 | Q8NAT1 | |
| TWHVFYADKYTCQDD | 121 | Q86V85 | |
| LACYFYEQAFREHWE | 486 | O75084 | |
| FKYCWENFVYNDDEP | 336 | Q8IUX4 | |
| AEAYCKTWSYREDAL | 441 | O60308 | |
| TFNVECYDEKTDEWY | 541 | Q6JEL2 | |
| CYYFSVEEKDWNSSL | 86 | Q96E93 | |
| YWQEFEDTCVYECLD | 396 | Q99928 | |
| YRDNYQAFCKWLYDA | 891 | P15924 | |
| FWDALDVDDYRFVYA | 211 | Q9H9V9 | |
| DYNYVWANCFEITLE | 336 | O75976 | |
| SDCEGFVTWQKYVDY | 101 | A8MWE9 | |
| CFEVFQTWDDEYEKL | 416 | Q14204 | |
| YYCNCDADYKQWRKD | 741 | Q9UHC6 | |
| AWEDTLDKYCDREYA | 361 | Q16610 | |
| LTADCNQDYDYLSDW | 756 | Q9ULB4 | |
| VDFAQARDDFYEWEC | 216 | Q8TC92 | |
| AWEDAKENYRYGLEC | 761 | Q659C4 | |
| YCYYFNEDRETWVDA | 46 | P05451 | |
| FTDQATFYDKRCDLW | 271 | Q9BUB5 | |
| EVDCTYFFTWDTEYA | 451 | P11717 | |
| KRFDIDSCTYYFSWD | 2106 | P11717 | |
| DYDWERECAIKFNDY | 1801 | Q93008 | |
| FIDDYQYDTEESLWC | 1511 | O95602 | |
| SEAYFENDCWVRYFL | 381 | P49589 | |
| ECFALYWEDNKFYRA | 561 | Q9H7E2 | |
| YWEDNKFYRAEVEAL | 566 | Q9H7E2 | |
| GYYIWTEDSFLCDKD | 71 | Q6P5X7 | |
| EGNEVCKYDYVEIWS | 666 | O43897 | |
| YDVQWECKTDLDIAY | 91 | Q96BY9 | |
| EDEADYYCAAWDDSL | 101 | A0A0B4J1U3 | |
| DFWFCESCQEYFVDE | 106 | Q9NQV5 | |
| KYWEFAVYLEECELA | 1786 | Q7Z333 | |
| YVENDFSWDKRYCEA | 186 | P08514 | |
| KVYFYWICRDARAFE | 436 | Q9HBY0 | |
| DEECEKASSTQYFWY | 136 | Q9NP91 | |
| KCISDVSNYDEVYWN | 491 | Q8IZF2 | |
| AAAECFVQSYWEQYK | 171 | O95455 | |
| AKWYDRRDYVFIEFC | 6 | Q15185 | |
| GAFDYWCKYDSRDIF | 211 | Q9UQR0 | |
| AVYDWNAKQFELYDE | 61 | O15066 | |
| KLARWEYDESYCDAV | 246 | O75063 | |
| EQCEYLSYDASQWEF | 826 | P35916 | |
| RFDYDWERECAIKFN | 1801 | O00507 | |
| WERECAIKFNDYFEF | 1806 | O00507 | |
| YWRECERDYQDDTLE | 1226 | P49750 | |
| WANYAAEALGCEYEE | 851 | Q8IUG5 | |
| EDTDTWLKYYDCDKY | 171 | P51523 | |
| RPAVEACYFNWEEAY | 476 | A7E2V4 | |
| EYSSLREEWKCEGYF | 121 | Q96NI8 | |
| FERLKNESRWSQCYY | 376 | Q8N584 | |
| EDYCMWRNYEYCRLD | 516 | O60264 | |
| WTHSDDYYKYCDEDS | 351 | Q8NG27 | |
| YDEKNWHYCDGYDRR | 76 | Q5VZ52 | |
| EQQYDSSYDARCDVW | 206 | Q8WXR4 |